A new case of de novo 11q duplication in a patient with normal development and intelligence and review of the literature

2007 ◽  
Vol 143A (3) ◽  
pp. 265-270 ◽  
Author(s):  
Yuri A. Zarate ◽  
Jillene M. Kogan ◽  
Elizabeth K. Schorry ◽  
Teresa A. Smolarek ◽  
Robert J. Hopkin
2021 ◽  
pp. 1071-1079
Author(s):  
Jennifer Y. Ge ◽  
Beth Overmoyer

Inflammatory breast cancer (IBC) is a rare type of breast cancer that is associated with poor outcomes compared with non-IBC. Overexpression of HER2 is enriched in IBC, and those with HER2-positive disease have a relatively favorable prognosis, with improved survival over the last two decades driven by the advent of novel targeted therapies. Here, we present two patients who have survived for over 10 years after being diagnosed with de novo metastatic HER2-positive IBC. We review the data for the treatments available for metastatic HER2-positive IBC and the evolving treatment recommendations for this disease.


2018 ◽  
Vol 28 (1) ◽  
pp. 53-56 ◽  
Author(s):  
QY Chen ◽  
XC Wang ◽  
WJ Wang ◽  
QH Zhou ◽  
DR Liu ◽  
...  

Author(s):  
Murat Sakir Eksi ◽  
Huseyin Kemal Turkoz ◽  
Emel Ece Ozcan Eksi ◽  
Akin Akakin ◽  
Zafer Orkun Toktas ◽  
...  

2021 ◽  
Author(s):  
J Sollors ◽  
B Kallinowski ◽  
T Gaiser ◽  
C Antoni ◽  
M Ebert ◽  
...  

2014 ◽  
Vol 44 (2) ◽  
pp. 241-245 ◽  
Author(s):  
Oren Gordon ◽  
Yotam Almagor ◽  
Dvora Fridler ◽  
Asaf Mandel ◽  
Hiba Qutteineh ◽  
...  

2019 ◽  
Vol 179 (3) ◽  
pp. 344-349 ◽  
Author(s):  
Ruth Cleaver ◽  
Jonathan Berg ◽  
Emily Craft ◽  
Alison Foster ◽  
Richard J. Gibbons ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document